Pharmaceutical companies are beginning to catch up with other
industry sectors that take an increasingly realistic view of what
they consider a core competency and outsourcing what is left -
Outsourcing-Pharma takes a snapshot of...
Minimising the risk of cross-contamination in the production of
medicines for use in clinical trials is a major challenge for
manufacturers, who need to implement safety measures in order to
avoid production failure.
GE Healthcare has launched a new contract offering that it claims
will cut the cost of running the service operations in life science
R&D labs by up to 20 per cent, at a time when pharma and
biotech firms are facing intense cost...